Multi-Modal Spectral Parametrization Method (MMSPM) for analyzing EEG activity with distinct scaling regimes
Frigyes Samuel Racz, John Milton, Juan Luis Cabrera, Gábor Csukly, José del R. Millán
Code Available — Be the first to reproduce this paper.
ReproduceCode
- github.com/samuelracz/MMSPMOfficialnone★ 2
Abstract
Aperiodic neural activity has been the subject of intense research interest lately as it could reflect on the cortical excitation/inhibition ratio, which is suspected to be affected in numerous clinical conditions. This phenomenon is characterized via the aperiodic scaling exponent , equal to the spectral slope following log-log transformation of power spectra. Despite recent progress, however, most current methods do not take into consideration the plausible multimodal nature in the power spectra of neurophysiological recordings - i.e., might be different in low- (_lo) and high-frequency (_hi) regimes -, especially in case of |_lo|>|_hi|. Here we propose an algorithm, the multi-modal spectral parametrization method (MMSPM) that aims to account for this issue. MMSPM estimates _lo and _hi separately using a constrained, piece-wise regression technique, and also assesses if they are significantly different or instead the spectrum is indeed unimodal and can be characterized simply with broadband . Here we present the MMSPM algorithm and evaluate its performance in silico on simulated power spectra. Then, we use MMSPM on resting-state electroencephalography (EEG) data collected from 19 young, healthy volunteers, as well as on a separate dataset of EEG recordings from 30 schizophrenia patients and 31 healthy controls, and demonstrate that broadband (0.1-100 Hz and 0.5-45 Hz) EEG spectra can indeed present a bimodality pattern with significantly steeper low-range (<2 Hz) and flatter high-range scaling regimes (i.e., |_lo|>|_hi|). Clinical relevance: The MMSPM method characterizes aperiodic neural activity in distinct scaling regimes, which can be relevant in numerous pathological conditions such as dementia or schizophrenia.